A 804598
A 804598 Basic information
- Product Name:
- A 804598
- Synonyms:
-
- A 804598
- N-Cyano-N′′-[(1S)-1-phenylethyl]-N′-5-quinolinyl-guanidine
- 1-cyano-2-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine
- 2-Cyano-1-[(1S)-1-phenylethyl]-3-(5-quinolinyl)guanidine
- A-804598 ((A 804598
- CS-2234
- Guanidine, N-cyano-N''-[(1S)-1-phenylethyl]-N'-5-quinolinyl-
- S-2-Cyano-1-(1-phenylethyl)-3-(quinolin-5-yl)guanidine
- CAS:
- 1125758-85-1
- MF:
- C19H17N5
- MW:
- 315.37
- Mol File:
- 1125758-85-1.mol
A 804598 Chemical Properties
- Boiling point:
- 498.0±47.0 °C(Predicted)
- Density
- 1.17±0.1 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,2-8°C
- solubility
- DMSO: soluble10mg/mL, clear
- pka
- 4.52±0.12(Predicted)
- form
- powder
- color
- white to beige
- InChI
- 1S/C19H17N5/c1-14(15-7-3-2-4-8-15)23-19(22-13-20)24-18-11-5-10-17-16(18)9-6-12-21-17/h2-12,14H,1H3,(H2,22,23,24)/t14-/m0/s1
- InChIKey
- PQYCRDPLPKGSME-AWEZNQCLSA-N
- SMILES
- N(c2c3c(nccc3)ccc2)\C(=N/[C@@H](C)c1ccccc1)\NC#N
A 804598 Usage And Synthesis
Uses
A 804598 is a P2X7 antagonist.
Biological Activity
a 804598 is a potent and selective antagonist of p2x7 receptor with ic50 values of 8.9, 9.9 and 10.9 nm for mouse, rat and human p2x7 receptors, respectively [1].p2x purinoceptor 7 (p2x7 receptor) is a purinoceptor and is activated by high concentrations of atp. p2x7 receptor plays an important role in atp-mediated cell death, inflammation and regulation of receptor trafficking.a 804598 is a potent and selective p2x7 receptor antagonist. in differentiated thp-1 cells that expressed human p2x7 receptors, a 804598 inhibited bzatp stimulated yo-pro uptake and release of il-1β. in 1321n1 cells expressed recombinant rat p2x7 receptor, a 804598 showed high affinity with kd = 2.4 nm [1]. a 804598 inhibited bz-atp stimulated calcium influx with ic50 value of 28.71 nm in a concentration-dependent way. a-804598 was a potent p2x7 receptor antagonist with ki value of 7.51 nm [2].in adult male rats, footshock increased the mrna levels of cd14 and il-1β in the paraventricular nucleus. while a-804598 (25 mg/kg) partially inhibited these effects [3].
in vivo
A chroni treatment with A-804598 (intraperitoneal injection; 30 mg/kg; five times a week) decreases the expression of LC3B-II and SQSTM1/p62 in lumbar spinal cord at end stage of disease[3].
| Animal Model: | Adult B6.Cg-Tg (SOD1-G93A) 1Gur/J female mice [3] |
| Dosage: | 30 mg/kg |
| Administration: | Intraperitoneal injection; five times a week |
| Result: | Decreased SQSTM1/p62 expression. |
IC 50
P2X7 Receptor
storage
Store at -20°C
References
[1]. donnelly-roberts dl, namovic mt, surber b, et al. [3h]a-804598 ([3h]2-cyano-1-[(1s)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for p2x7 receptors. neuropharmacology, 2009, 56(1): 223-229.
[2]. able sl, fish rl, bye h, et al. receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant p2x7 antagonists in the rat. br j pharmacol. 2011, 162(2): 405-414.
[3]. catanzaro jm1, hueston cm, deak mm, et al. the impact of the p2x7 receptor antagonist a-804598 on neuroimmune and behavioral consequences of stress. behav pharmacol, 2014, 25(5-6): 582-598.
A 804598Supplier
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- 025-66113011 17798518460
- cfzhang@aikonchem.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 020-39119399 18927568969
- isunpharm@qq.com
- Tel
- 400-400-164-7117 18317119277
- product02@bidepharm.com